Literature DB >> 32530771

Vaccine-associated Rubella - a report of two cases and a review of the literature.

Sean Wei Xiang Ong1,2, Shawn Vasoo1,2,3,4, Sapna P Sadarangani1,2,3, Lin Cui5, Kalisvar Marimuthu1,2,4, Poh Lian Lim1,2,3,4, Jing Wen Kong3,6, Judith Chui Ching Wong7,8, Kim Yoong Puong8, Kwai Peng Chan8,9.   

Abstract

We report the clinical characteristics of two adult patients, presenting with a typical erythematous rash consistent with rubella disease after MMR vaccination. Both patients had an uncomplicated clinical course and recovered uneventfully. One patient was confirmed to have vaccine-associated rubella via sequencing of virus isolated in viral culture. The other patient had a pharyngeal swab positive for rubella virus PCR, with sequencing matching the vaccine strain. There are few reports of clinical disease from rubella vaccine-strains in the literature. Previous authors have reported severe disseminated vaccine-associated rubella in both immunodeficient and immunocompetent patients. Further study is required to ascertain the incidence, risk factors, and clinical characteristics of this condition; as well as investigate the extent of horizontal transmission to guide infection control recommendations.

Entities:  

Keywords:  MMR; Rubella; genotyping; vaccine; vaccine strain

Year:  2020        PMID: 32530771      PMCID: PMC7872085          DOI: 10.1080/21645515.2020.1765623

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  16 in total

Review 1.  Rubella virus replication and links to teratogenicity.

Authors:  J Y Lee; D S Bowden
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Rubella virus nomenclature update: 2013.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2013-08-09

Review 3.  Rubella and pregnancy: diagnosis, management and outcomes.

Authors:  Elise Bouthry; Olivier Picone; Ghada Hamdi; Liliane Grangeot-Keros; Jean-Marc Ayoubi; Christelle Vauloup-Fellous
Journal:  Prenat Diagn       Date:  2014-09-16       Impact factor: 3.050

4.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

5.  Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor.

Authors:  N Ono; H Tatsuo; Y Hidaka; T Aoki; H Minagawa; Y Yanagi
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Fulminant encephalitis associated with a vaccine strain of rubella virus.

Authors:  Felipe Augusto Souza Gualberto; Maria Isabel de Oliveira; Venancio A F Alves; Cristina T Kanamura; Sérgio Rosemberg; Helena Keico Sato; Benedito A F Arantes; Suely Pires Curti; Cristina Adelaide Figueiredo
Journal:  J Clin Virol       Date:  2013-10-24       Impact factor: 3.168

7.  Effect of immunization against rubella on lactation products. II. Maternal-neonatal interactions.

Authors:  G A Losonsky; J M Fishaut; J Strussenberg; P L Ogra
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

8.  Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia.

Authors:  A J Tingle; J K Chantler; K H Pot; D W Paty; D K Ford
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

9.  Transmission of rubella vaccine virus from vaccinees to contacts.

Authors:  J Wilkins; J M Leedom; M A Salvatore; B Portnoy
Journal:  Calif Med       Date:  1971-11

10.  Vaccine Rubella: A Rare Cause of Post-transplant Hematopoietic Death, but a Major Public Health Problem.

Authors:  Marta Gonzalez Vicent; Blanca Molina Angulo; Juan Emilio Echevarría Mayo; Miguel Angel Diaz Perez
Journal:  Open Forum Infect Dis       Date:  2018-09-15       Impact factor: 3.835

View more
  1 in total

1.  Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant.

Authors:  Michaël Desjardins; Xhoi Mitre; Amy C Sherman; Stephen R Walsh; Matthew P Cheng; Sanjat Kanjilal; Vincent T Ho; Lindsey R Baden; Nicolas C Issa
Journal:  Open Forum Infect Dis       Date:  2021-11-23       Impact factor: 3.835

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.